Clinical Trials

Search for actively enrolling clinical trials

AHOD1331, A Randomized Phase III Study of Brentuximab Vedotin (SGN-35, IND #117117) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Adolescents

Study ID: STU 042015-028

Summary

See protocol/CiRB application

Participant Eligibility

See protocol/CIRB Application

Cancer Related
Healthy Volunteers
No
UT Southwestern Principal Investigator
Martha Marie Pacheco

Contact:

AMANDA RICHARDS

AMANDA.RICHARDS@childrens.com

Linked In Email
scroll to top